These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1509386

  • 1. [The clinico-pathogenetic variants of cholestasis in different liver diseases].
    Ivashkin VT, Ivlev AS, Pliusnin SV, Vasil'ev AP.
    Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386
    [Abstract] [Full Text] [Related]

  • 2. [The epidemiology of cholestasis in hepatopathies].
    Budillon G.
    Ann Ital Med Int; 1993 Oct; 8 Suppl():36S-40S. PubMed ID: 7906951
    [Abstract] [Full Text] [Related]

  • 3. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B, Palynyczko Z.
    Pol Med Sci Hist Bull (1973); 1975 Oct; 15(5-6):551-5. PubMed ID: 1228704
    [Abstract] [Full Text] [Related]

  • 4. [Plasma fibronectin in chronic liver diseases].
    Soresi M, Di Martino D, Montalto G, Carroccio A, Ruggeri MI, Bascone F, Ippolito S, Notarbartolo A.
    Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
    [Abstract] [Full Text] [Related]

  • 5. Role of autoimmunity in nonviral chronic liver disease.
    Amarapurkar DN, Amarapurkar AD.
    J Assoc Physicians India; 2000 Nov; 48(11):1064-9. PubMed ID: 11310382
    [Abstract] [Full Text] [Related]

  • 6. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
    Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, Trautwein C, Brabant G.
    J Hepatol; 2005 May; 42(5):666-73. PubMed ID: 15826715
    [Abstract] [Full Text] [Related]

  • 7. [Alkaline leucocyte phosphatase (ALP) in acute and chronic liver diseases].
    Krug K, Stenzel L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973 May; 99(2):170-9. PubMed ID: 4122960
    [No Abstract] [Full Text] [Related]

  • 8. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
    Simon K, Zalewska M, Gładysz A, Rotter K, Piszko P, Głowacki A.
    Przegl Lek; 1995 May; 52(4):129-32. PubMed ID: 7638358
    [Abstract] [Full Text] [Related]

  • 9. [Cholestasis assessment by activity of antioxidant enzymes and composition of plasma lipoproteins in patients with liver diseases].
    Loginov AS, Matiushin BN, Chebanov SM, Reshetniak VI.
    Ter Arkh; 1998 May; 70(4):40-2. PubMed ID: 9612901
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].
    Aprosina ZG, Lopatkina TN, Iakovenko EP, Krel' PE, Saiapina ES.
    Ter Arkh; 1988 May; 60(11):23-8. PubMed ID: 3238571
    [Abstract] [Full Text] [Related]

  • 11. [A new approach to the diagnosis of cholestasis by the activity of copper-containing enzymes].
    Loginov AS, Matiushin BN, Tkachev VD, Iakimchuk GN.
    Ter Arkh; 1993 May; 65(2):34-6. PubMed ID: 9133006
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J, Lovell G, Heubi J.
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnostic importance of leucine aminopeptidase. I.
    Vaedtke J.
    Pol Med J; 1970 Jul; 9(6):1317-25. PubMed ID: 5505046
    [No Abstract] [Full Text] [Related]

  • 16. [Bile acids in chronic hepatopathies].
    Luciani A, Massari M, Montanari P, Nora A, Zandomeneghi R.
    Minerva Med; 1986 Dec 22; 77(49-50):2287-92. PubMed ID: 3808385
    [Abstract] [Full Text] [Related]

  • 17. [Variations in serum kininase II activity in acute jaundice].
    Olivero S, Sciascia C, Mao P, Arione R, Enrichens F, Alberghina A, Festa T, Pessione E, Sanfelici G.
    Minerva Med; 1986 May 07; 77(19):793-8. PubMed ID: 3012414
    [Abstract] [Full Text] [Related]

  • 18. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C.
    Benini F, Pigozzi MG, Baisini O, Romanini L, Ahmed H, Pozzi A, Ricci C, Lanzini A.
    J Gastroenterol Hepatol; 2007 Oct 07; 22(10):1621-6. PubMed ID: 17845689
    [Abstract] [Full Text] [Related]

  • 19. [Changes in the lipid profile in chronic hepatopathies].
    Perales J, Angel Lasunción M, Cano A, Martín-Scapa MA, Matíes M, Herrera E.
    Med Clin (Barc); 1994 Mar 19; 102(10):364-8. PubMed ID: 8182981
    [Abstract] [Full Text] [Related]

  • 20. [Critical evaluation of the serum enzymatic diagnosis of liver diseases].
    Sposito M, Albertini Petroni V, Hassan G, Marinucci G, Valeri L.
    Quad Sclavo Diagn; 1971 Dec 19; 7(4):1036-49. PubMed ID: 4144704
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.